Why the study?
Does preoperative risk stratification and medical optimization reduce perioperative morbidity and mortality in patients with peripheral arterial disease undergoing vascular surgery?
Does preoperative risk stratification and medical optimization reduce perioperative morbidity and mortality in patients with peripheral arterial disease undergoing vascular surgery?
Preoperative risk stratification and targeted medical optimization (beta blockers, statins, smoking cessation) are recommended to reduce perioperative risk in patients undergoing vascular surgery.
Answers are grounded in this paper and cite their sources.
Supports perioperative optimization in vascular surgery patients; Level 5 evidence leaves mortality benefit open to RCT confirmation.
Patients with peripheral arterial disease have a high rate of cardiac, cerebrovascular, or pulmonary comorbidities. Peripheral arterial surgical interventions are associated with a moderate to high perioperative cardiac risk. Simple clinical scoring systems for preoperative risk stratification can be used to identify high-risk patients. In these patients further diagnostic and therapeutic measures are required to reduce perioperative morbidity and mortality. In contrast, a group of patients can be identifed that do not require additional cardiopulmonary diagnostics and can immediately proceed to the intervention. According to evidence-based recommendations in patients at risk beta blocker should be uptitrated and statin therapy should be initiated preoperatively. Quitting smoking preoperatively also reduces perioperative complications and should be encouraged in all patients.
No takes yet. Share an insight, caveat, or question.
Mahlmann et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: